Hancock Whitney Corp Grows Stock Position in UnitedHealth Group Inc (NYSE:UNH)

Share on StockTwits

Hancock Whitney Corp grew its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.8% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 7,916 shares of the healthcare conglomerate’s stock after purchasing an additional 218 shares during the quarter. Hancock Whitney Corp’s holdings in UnitedHealth Group were worth $2,327,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in UNH. Johanson Financial Advisors Inc. increased its position in shares of UnitedHealth Group by 28,935.9% during the 4th quarter. Johanson Financial Advisors Inc. now owns 3,384,419 shares of the healthcare conglomerate’s stock valued at $11,512,000 after purchasing an additional 3,372,763 shares during the last quarter. M&G Investment Management Ltd. purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $231,806,000. Sanders Capital LLC increased its position in shares of UnitedHealth Group by 11.6% during the 4th quarter. Sanders Capital LLC now owns 5,178,244 shares of the healthcare conglomerate’s stock valued at $1,708,324,000 after purchasing an additional 539,880 shares during the last quarter. Nomura Holdings Inc. increased its position in shares of UnitedHealth Group by 474.5% during the 3rd quarter. Nomura Holdings Inc. now owns 561,936 shares of the healthcare conglomerate’s stock valued at $122,846,000 after purchasing an additional 464,121 shares during the last quarter. Finally, Assenagon Asset Management S.A. increased its position in shares of UnitedHealth Group by 29,257.1% during the 4th quarter. Assenagon Asset Management S.A. now owns 440,356 shares of the healthcare conglomerate’s stock valued at $129,456,000 after purchasing an additional 438,856 shares during the last quarter. 85.81% of the stock is owned by hedge funds and other institutional investors.

In other UnitedHealth Group news, EVP D Ellen Wilson sold 7,400 shares of the company’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $272.77, for a total value of $2,018,498.00. Also, Director Richard T. Burke sold 15,000 shares of the company’s stock in a transaction that occurred on Thursday, January 16th. The stock was sold at an average price of $299.45, for a total value of $4,491,750.00. Following the completion of the transaction, the director now owns 158,598 shares of the company’s stock, valued at $47,492,171.10. The disclosure for this sale can be found here. Corporate insiders own 0.82% of the company’s stock.

Shares of NYSE:UNH opened at $298.78 on Friday. The stock has a 50 day moving average of $291.46 and a 200 day moving average of $260.43. The company has a market cap of $283.07 billion, a PE ratio of 20.85, a price-to-earnings-growth ratio of 1.41 and a beta of 0.69. The company has a current ratio of 0.69, a quick ratio of 0.70 and a debt-to-equity ratio of 0.61. UnitedHealth Group Inc has a 12-month low of $208.07 and a 12-month high of $305.90.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Wednesday, January 15th. The healthcare conglomerate reported $3.90 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.77 by $0.13. The company had revenue of $60.90 billion during the quarter, compared to the consensus estimate of $61.17 billion. UnitedHealth Group had a return on equity of 25.55% and a net margin of 5.71%. The firm’s revenue was up 4.3% on a year-over-year basis. During the same period in the previous year, the company posted $3.28 EPS. Equities research analysts predict that UnitedHealth Group Inc will post 16.47 earnings per share for the current fiscal year.

Several research firms have recently commented on UNH. Wells Fargo & Co reaffirmed an “overweight” rating and set a $335.00 price target (up previously from $318.00) on shares of UnitedHealth Group in a research report on Wednesday, December 11th. Piper Jaffray Companies upped their price target on shares of UnitedHealth Group from $312.00 to $325.00 and gave the company an “overweight” rating in a research report on Wednesday, December 4th. Citigroup upped their price target on shares of UnitedHealth Group from $286.00 to $346.00 and gave the company a “buy” rating in a research report on Thursday, January 16th. Mizuho reaffirmed a “buy” rating and set a $300.00 price target (up previously from $270.00) on shares of UnitedHealth Group in a research report on Tuesday, November 26th. Finally, Argus reaffirmed a “buy” rating and set a $340.00 price target on shares of UnitedHealth Group in a research report on Thursday, December 19th. Five equities research analysts have rated the stock with a hold rating and nineteen have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $313.50.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: Profit Margin

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.